CMV gB vaccine long term antibody response. Version 1.0 13November2012

• Research type

  Research Study

• Full title

  Long term antibody response to CMV gB vaccine in patients requiring liver or renal transplant. A Phase II open, single-site study, in participants who received CMV gB vaccine or placebo in previous trial (CTA ref no 20363/0238/001-0010; REC ref no 5476; UCL sponsor no 05/009).

• IRAS ID

  112951

• Contact name

  Paul Griffiths

• Contact email

  p.griffiths@medsch.ucl.ac.uk

• Sponsor organisation

  The Comprehensive Clinical Trials Unit, University College London

• Eudract number

  2012-002767-95

• ISRCTN Number

  n/a

• REC name

  London - Hampstead Research Ethics Committee

• REC reference

  13/LO/0335

• Date of REC Opinion

  17 Jun 2013

• REC opinion

  Further Information Favourable Opinion